EVALUATION OF THE CLINICAL UTILITY OF A NOVEL FORMULATION OF FUROSEMIDE DELIVERED SUBCUTANEOUSLY IN PATIENTS PRESENTING WITH EARLY SIGNS OF FLUID OVERLOAD

Autor:	Maxwell Afari, Margaret Michaelian, Lana Tsao, Jaclyn Lemoine, Argyro Papafilippaki
Rok vydání:	2020
Předmět:	business.industry Early signs Anesthesia Heart failure medicine Furosemide Diuresis In patient Cardiology and Cardiovascular Medicine business medicine.disease medicine.drug
Zdroj:	Journal of the American College of Cardiology. 75:950
ISSN:	0735-1097
DOI:	10.1016/s0735-1097(20)31577-1
Popis:	Over a million patients are hospitalized for heart failure (HF) annually, usually for IV diuresis. Readmission rates at 30 days and 6 months are estimated to be 25% and 50%, respectively. Subcutaneous (SC) furosemide has been proposed as an alternative to parenteral delivery of diuresis in the
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_________::69df2f79107a64ee27bb6b5030f0cba3 https://doi.org/10.1016/s0735-1097(20)31577-1 Zobrazit plný text záznamu